EUVIMEDEUVIMED entdecken
Crossref

Leveraging induced cell states for cancer therapy: The case for dynamic synthetic lethality

Christina Mayerhofer, David T Scadden

Cell Metabolism · 2026-11 · 38 (11) · 2173-2177

DOI: 10.1016/j.cmet.2026.08.017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Metabolism, 2026-11. Verfasst von Christina Mayerhofer und 1 weiteren Autor:innen. Beteiligte Einrichtung: Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA; Harvard Stem Cell Institute, Department of Stem Cell and R…. Hauptthemen laut MEDLINE: Neoplasms, Antineoplastic Agents, Synthetic Lethal Mutations. Die Arbeit nennt 14 Literaturangaben. Gefördert von: German Cancer Consortium, NCI, German Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic differences between cancer and normal cells are accentuated by the selection pressure of therapy. Persisting cells enter a therapy-induced state of heightened, time-limited metabolic dependency. We argue that this interval can be exploited with metabolic modifiers to achieve persister cell death and improve cancer outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsAntineoplastic AgentsSynthetic Lethal MutationsHumansAnimals

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA; Harvard Stem Cell Institute, Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA; Departmen…
  • Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA; Harvard Stem Cell Institute, Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA; Harvard M…

Förderung

  • German Cancer Consortium
  • NCI
  • German Research Foundation

Zitieren

APA

Mayerhofer, C., & Scadden, D. T. (2026). Leveraging induced cell states for cancer therapy: The case for dynamic synthetic lethality. Cell Metabolism, 38(11), 2173-2177. https://doi.org/10.1016/j.cmet.2026.08.017

Vancouver

Mayerhofer C, Scadden DT. Leveraging induced cell states for cancer therapy: The case for dynamic synthetic lethality. Cell Metabolism. 2026;38(11):2173-2177. doi:10.1016/j.cmet.2026.08.017

BibTeX
@article{Mayerhofer2026,
  author = {Mayerhofer, Christina and Scadden, David T},
  title = {Leveraging induced cell states for cancer therapy: The case for dynamic synthetic lethality},
  journal = {Cell Metabolism},
  year = {2026},
  volume = {38},
  number = {11},
  pages = {2173--2177},
  doi = {10.1016/j.cmet.2026.08.017}
}
Kostenlos starten →